Evidence map›Paper›PMID 31556993›Full record

ArticleACS chemical biology2020

Inhibiting

Huiqing Zheng, John T Williams, Bilal Aleiwi, Edmund Ellsworth, Robert B Abramovitch

Open access · hybridAbstract read
In one paragraph

Article in ACS chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. mBio · 2026
    Article
  5. bioRxiv : the preprint server for biology · 2025
    Article
  6. AACS synthetic biology · 2025
    Article
  7. Genetic and Cheminformatic Characterization ofACS infectious diseases · 2025
    Article
  8. Review
  9. Medicinal plants as more sustainable therapeutic solutions:Global health economics and sustainability · 2025
    Article
  10. The DosR regulon ofFrontiers in cellular and infection microbiology · 2025
    Article
  11. TowardMicroorganisms · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Antibiotic failure: Beyond antimicrobial resistance.Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy · 2023
    Review
  18. Article
  19. Metalloprotein enabled redox signal transduction in microbes.Current opinion in chemical biology · 2023
    Review
  20. MedComm · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Huiqing Zheng
John T Williams
Bilal Aleiwi
Edmund Ellsworth
Robert B AbramovitchORCID 0000-0002-4119-4169
Michigan State University · US

Funding

Mechanisms of Mycobacterium Tuberculosis pH-driven AdaptationR01AI116605 · NIAID · MICHIGAN STATE UNIVERSITY · PI ABRAMOVITCH, ROBERT B · 2016 to 2020
$1.9M
Synthetic Fabs for Crystallization of Chemokine:Receptor ComplexesR21AI101687 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HANDEL, TRACY M · 2012 to 2013
$415k
Screening for inhibitors of M. tuberculosis persistence-related lipid metabolismR21AI105867 · NIAID · MICHIGAN STATE UNIVERSITY · PI ABRAMOVITCH, ROBERT B · 2013 to 2014
$392k
NIAID NIH HHS R01 AI116605NIAID NIH HHS R21 AI101687NIAID NIH HHS R21 AI105867
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsDNADNA-Binding ProteinsDrug Evaluation, PreclinicalGene Expression Regulation, BacterialHemeHomeostasisMolecular StructureMycobacterium tuberculosisOxidation-ReductionProtein Kinase InhibitorsSignal TransductionStructure-Activity RelationshipAnti-Bacterial AgentsBacterial ProteinsDNADNA-Binding ProteinsDosR protein, Mycobacterium tuberculosisHemeProtein Kinase Inhibitors

Identifiers

PMID31556993
PMCPMC6970277
OpenAlexW2976346060

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.